These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38557758)

  • 21. Impairment of colorectal cancer screening during the COVID-19 pandemic.
    Semenov S; Ismail MS; McNamara D
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):426. PubMed ID: 34015353
    [No Abstract]   [Full Text] [Related]  

  • 22. Impairment of colorectal cancer screening during the COVID-19 pandemic.
    Laghi L; Cameletti M; Ferrari C; Ricciardiello L
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):425-426. PubMed ID: 34015352
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of cancer screening restart strategies after COVID-19 disruption.
    Kregting LM; Kaljouw S; de Jonge L; Jansen EEL; Peterse EFP; Heijnsdijk EAM; van Ravesteyn NT; Lansdorp-Vogelaar I; de Kok IMCM
    Br J Cancer; 2021 Apr; 124(9):1516-1523. PubMed ID: 33723386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.
    Walker MJ; Meggetto O; Gao J; Espino-Hernández G; Jembere N; Bravo CA; Rey M; Aslam U; Sheppard AJ; Lofters AK; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Rabeneck L
    Prev Med; 2021 Oct; 151():106586. PubMed ID: 34217413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
    Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
    Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
    Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
    Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study.
    Lal A; Gao L; Tan E; McCaffrey N; Roder D; Buckley E
    PLoS One; 2022; 17(12):e0279177. PubMed ID: 36542644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
    Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
    World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
    Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
    BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
    Mazidimoradi A; Tiznobaik A; Salehiniya H
    J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the COVID-19 pandemic on cancer screenings in Portugal.
    Mendes D; Figueiredo D; Alves C; Penedones A; Costa B; Batel-Marques F
    Cancer Epidemiol; 2024 Feb; 88():102496. PubMed ID: 38061274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of family history-based colorectal cancer screening in Australia.
    Ouakrim DA; Boussioutas A; Lockett T; Hopper JL; Jenkins MA
    BMC Cancer; 2014 Apr; 14():261. PubMed ID: 24735237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring the impact of the COVID-19 pandemic on colorectal cancer presentation: a retrospective comparative study.
    Fullard K; Steffens D; Solomon M; Shin JS; Koh C
    ANZ J Surg; 2023 Dec; 93(12):2951-2957. PubMed ID: 37846781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis.
    Weiss DJ; Bertozzi-Villa A; Rumisha SF; Amratia P; Arambepola R; Battle KE; Cameron E; Chestnutt E; Gibson HS; Harris J; Keddie S; Millar JJ; Rozier J; Symons TL; Vargas-Ruiz C; Hay SI; Smith DL; Alonso PL; Noor AM; Bhatt S; Gething PW
    Lancet Infect Dis; 2021 Jan; 21(1):59-69. PubMed ID: 32971006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of colorectal cancer outcomes for the Australian National Bowel Cancer Screening Program.
    ;
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):22-32. PubMed ID: 26803949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
    Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
    PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.